Clinical trial
An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic…
NCT00002089 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00002089 |
|---|---|
| Title | An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy |
| Official title | An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Mycobacterium Avium-Intracellulare Infection, HIV Infections |
| Intervention type | Drug |
| Interventions | Azithromycin |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: